These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9743230)

  • 21. Arg123-Tyr166 domain of human ApoA-I is critical for HDL-mediated inhibition of macrophage homing and early atherosclerosis in mice.
    Holvoet P; Peeters K; Lund-Katz S; Mertens A; Verhamme P; Quarck R; Stengel D; Lox M; Deridder E; Bernar H; Nickel M; Theilmeier G; Ninio E; Phillips MC
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1977-83. PubMed ID: 11742873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice.
    Sorci-Thomas MG; Zabalawi M; Bharadwaj MS; Wilhelm AJ; Owen JS; Asztalos BF; Bhat S; Thomas MJ
    Biochim Biophys Acta; 2012 Mar; 1821(3):502-12. PubMed ID: 21944998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix metalloproteinase 8 degrades apolipoprotein A-I and reduces its cholesterol efflux capacity.
    Salminen A; Åström P; Metso J; Soliymani R; Salo T; Jauhiainen M; Pussinen PJ; Sorsa T
    FASEB J; 2015 Apr; 29(4):1435-45. PubMed ID: 25550459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
    Chroni A; Kan HY; Kypreos KE; Gorshkova IN; Shkodrani A; Zannis VI
    Biochemistry; 2004 Aug; 43(32):10442-57. PubMed ID: 15301543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance of smooth muscle cells to assembly of high density lipoproteins with extracellular free apolipoproteins and to reduction of intracellularly accumulated cholesterol.
    Komaba A; Li Q; Hara H; Yokoyama S
    J Biol Chem; 1992 Sep; 267(25):17560-6. PubMed ID: 1517206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and partial characterization of lipoprotein A-II (LP-A-II) particles of human plasma.
    Bekaert ED; Alaupovic P; Knight-Gibson C; Norum RA; Laux MJ; Ayrault-Jarrier M
    Biochim Biophys Acta; 1992 Jun; 1126(1):105-13. PubMed ID: 1606170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in mice.
    Tiniakou I; Kanaki Z; Georgopoulos S; Chroni A; Van Eck M; Fotakis P; Zannis VI; Kardassis D
    Atherosclerosis; 2015 Nov; 243(1):77-85. PubMed ID: 26363436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats.
    Fournier N; de la Llera Moya M; Burkey BF; Swaney JB; Paterniti J; Moatti N; Atger V; Rothblat GH
    J Lipid Res; 1996 Aug; 37(8):1704-11. PubMed ID: 8864954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice.
    Hedrick CC; Castellani LW; Warden CH; Puppione DL; Lusis AJ
    J Biol Chem; 1993 Sep; 268(27):20676-82. PubMed ID: 8376417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions.
    Hedrick CC; Castellani LW; Wong H; Lusis AJ
    J Lipid Res; 2001 Apr; 42(4):563-70. PubMed ID: 11290828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lecithin:cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux.
    Czarnecka H; Yokoyama S
    Biochemistry; 1995 Apr; 34(13):4385-92. PubMed ID: 7703252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein B-100 and apoA-II kinetics as determinants of cellular cholesterol efflux.
    Chan DC; Hoang A; Barrett PH; Wong AT; Nestel PJ; Sviridov D; Watts GF
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1658-66. PubMed ID: 22745238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins.
    Rosales C; Gillard BK; Courtney HS; Blanco-Vaca F; Pownall HJ
    Biochemistry; 2009 Aug; 48(33):8070-6. PubMed ID: 19618959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SAA-only HDL formed during the acute phase response in apoA-I+/+ and apoA-I-/- mice.
    Cabana VG; Reardon CA; Wei B; Lukens JR; Getz GS
    J Lipid Res; 1999 Jun; 40(6):1090-103. PubMed ID: 10357841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholesterol efflux from Fu5AH cells to the serum of patients with Alagille syndrome. Importance of the hdl-phospholipids/free cholesterol ratio and of the hdl size distribution.
    Davit-Spraul A; Atger V; Pourci ML; Hadchouel M; Legrand A; Moatti N
    J Lipid Res; 1999 Feb; 40(2):328-35. PubMed ID: 9925663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles.
    Sviridov D; Pyle L; Fidge N
    Biochemistry; 1996 Jan; 35(1):189-96. PubMed ID: 8555173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein.
    Blanco-Vaca F; Escolà-Gil JC; Martín-Campos JM; Julve J
    J Lipid Res; 2001 Nov; 42(11):1727-39. PubMed ID: 11714842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A selective peroxisome proliferator-activated receptor δ agonist PYPEP suppresses atherosclerosis in association with improvement of the serum lipoprotein profiles in human apolipoprotein B100 and cholesteryl ester transfer protein double transgenic mice.
    Naya N; Fukao K; Nakamura A; Hamada T; Sugimoto M; Kojima M; Yoshimura N; Uwabe K; Imagawa K; Nomura K; Hara S; Nakano T; Iwasaki T; Shinosaki T; Hanasaki K
    Metabolism; 2016 Jan; 65(1):16-25. PubMed ID: 26683793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of apolipoprotein O does not impact on plasma HDL levels or functionality in human apolipoprotein A-I transgenic mice.
    Nijstad N; de Boer JF; Lagor WR; Toelle M; Usher D; Annema W; der Giet Mv; Rader DJ; Tietge UJ
    Biochim Biophys Acta; 2011 Apr; 1811(4):294-9. PubMed ID: 21296681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice.
    Tardy C; Goffinet M; Boubekeur N; Ackermann R; Sy G; Bluteau A; Cholez G; Keyserling C; Lalwani N; Paolini JF; Dasseux JL; Barbaras R; Baron R
    Atherosclerosis; 2014 Jan; 232(1):110-8. PubMed ID: 24401224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.